Presented at the international conference of the European Association for Behavioural and Cognitive Therapies

TOKYO, Sept. 17, 2021 /PRNewswire/ — Jolly Good and National Center of Neurology and Psychiatry have verified the efficacy of using VR in Cognitive Behavioral Therapy (CBT) for patients suffering depression in Japan.

Results indicate improvement in the scores of the targeted patients with depression. Use of VR caused no adverse events, demonstrating that VR can be used safely in the CBT for of depression.

This research was conducted by the Japanese medical startup company Jolly Good Inc. and the National Center of Neurology and Psychiatry, Japan’s largest cognitive behavioral therapy research institute.

The result was presented at the international conference of the European Association for Behavioural Cognitive Therapies (EABCT) held in Northern Ireland on Saturday, September 11, 2021. (Presenter: Asami Komazawa)

EABCT